Skip to main content
Clinical Trials/CTRI/2020/05/025157
CTRI/2020/05/025157CompletedPhase 4

Single-blind, randomized study comparing clinical equivalence of Trulene�® and Prolene�® polypropylene sutures in elective primary coronary artery bypass graft surgery

Healthium Medtech Pvt Ltd formerly Sutures India Pvt Ltd0 sites92 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
92

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Male or female subjects above 18 years, scheduled for elective primary coronary artery bypass graft surgery
  • 2. Subjects who have given written informed consent

Exclusion Criteria

  • 1. Subjects with a history of CABG
  • 2. Subjects who require other combined valve intervention
  • 3. Subjects having active infection at or around the skin incision site
  • 4. Subjects with history of allergy to polypropylene or similar products
  • 5. Subjects with history of bleeding disorders
  • 6. Subjects already participating in another cardiovascular study
  • 7. Subjects who received an experimental drug or used an experimental medical device within 30 days prior to the planned start of procedure
  • 8. Subjects unlikely to comply with surgical procedure or complete the scheduled follow up visit, in the opinion of investigator
  • 9. Employees of the investigator or study center with direct involvement in the proposed study or other studies under the direction of that investigator or study center
  • 10. Subjects with mental disorder, learning disability, or language barrier
  • 11. Other indication-based exclusion, in opinion of investigator

Investigators

Sponsor
Healthium Medtech Pvt Ltd formerly Sutures India Pvt Ltd

Similar Trials